Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
about
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive DisordersNew insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathyCentral Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationViral miRNAs in plasma and urine divulge JC polyomavirus infection.Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarateDimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.Detection of Malawi polyomavirus sequences in secondary lymphoid tissues from Italian healthy children: a transient site of infection.Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects.Reactivation of human polyomaviruses in immunocompromised states.Is specific HIV eradication from the brain possible or needed?Dimethyl fumarate for treating relapsing multiple sclerosis.B cells and progressive multifocal leukoencephalopathy: search for the missing linkDrug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.Viral infections in prostate carcinomas in Chilean patients.HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.Drugs approved for the treatment of multiple sclerosis: review of their safety profile.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.
P2860
Q26741723-D5C00D65-BA32-4A13-A538-457CC9D0704AQ26822247-C73E83DD-0CAA-43F5-B9FF-8E503BD40357Q33679931-04282278-E0C6-4BF3-8020-D5DCB81C1666Q34208184-C3840D63-9123-413F-A570-30A63B78FD87Q35685505-B6D1215C-7B11-48F2-B400-4F95FA9E20DEQ36257412-0830AC18-008F-494E-9AA7-4598851A49D6Q36626711-66B5DFCF-D336-4DC1-8915-FD9C22A346A8Q36991114-CA904BBC-9BF7-4AE2-A344-50871B87F57BQ37361949-BF740E25-8501-497B-9D5F-494453EC56B7Q37570005-373A8AA1-1547-49C2-8A05-F8BF6234AE4DQ37621983-EE377063-049B-40FE-889B-3F340DB73B7CQ37725435-F009D8F2-8DD9-4845-AEF7-EF0C98F733F3Q38071699-7B6472B3-2CCD-4983-96A1-92264740F970Q38266397-5B15E8CF-6B6C-4858-9B1C-4D13F0DAFA39Q38515349-AF9A7FEA-910B-4206-BF83-95AD43B1361DQ39046213-ACA2F4AB-CA74-4AA4-B556-BB38F8194242Q40965913-389FF44A-78E3-428A-8119-9AD4D0205454Q41020481-896F3136-59E5-4A59-A7D9-068190876AD7Q41509979-D03C9DF4-C706-4050-8195-DBED8DCC4CF1Q47868767-7FF0996B-26C2-4666-9072-0FD4F448D59BQ49884884-4FB0AEB0-D932-49E2-9E1F-E17B8BB4D343Q49906338-2104A04E-8925-423C-82D1-F31C283D5E5E
P2860
Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@en
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@nl
type
label
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@en
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@nl
prefLabel
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@en
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@nl
P2093
P2860
P921
P1476
Human polyomavirus JC reactiva ...... monoclonal antibody therapies.
@en
P2093
A Bellizzi
E Anzivino
F Chiarini
M Mischitelli
P2860
P2888
P356
10.1007/S13365-012-0080-7
P577
2012-02-01T00:00:00Z